Novel antimicrobial peptides derived from human immunodeficiency virus type 1 and other lentivirus transmembrane proteins.
about
Cytopathic Mechanisms of HIV-1"Specificity Determinants" Improve Therapeutic Indices of Two Antimicrobial Peptides Piscidin 1 and Dermaseptin S4 Against the Gram-negative Pathogens Acinetobacter baumannii and Pseudomonas aeruginosaPeptide antibiotics.Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications.Inactivation of herpes simplex virus clinical isolates by using a combination microbicideRational design of α-helical antimicrobial peptides to target Gram-negative pathogens, Acinetobacter baumannii and Pseudomonas aeruginosa: utilization of charge, 'specificity determinants,' total hydrophobicity, hydrophobe type and location as desigDe novo-derived cationic antimicrobial peptide activity in a murine model of Pseudomonas aeruginosa bacteraemia.A lipid-peptide microbicide inactivates herpes simplex virus.Rational design of engineered cationic antimicrobial peptides consisting exclusively of arginine and tryptophan, and their activity against multidrug-resistant pathogens.A proapoptotic peptide derived from reovirus outer capsid protein {micro}1 has membrane-destabilizing activity.Lentivirus lytic peptide 1 perturbs both outer and inner membranes of Serratia marcescens.De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activityComparative functional properties of engineered cationic antimicrobial peptides consisting exclusively of tryptophan and either lysine or arginine.Modulation of proinflammatory activity by the engineered cationic antimicrobial peptide WLBU-2.Viroporin potential of the lentivirus lytic peptide (LLP) domains of the HIV-1 gp41 protein.Efficacy of the de novo-derived antimicrobial peptide WLBU2 against oral bacteria.Differential functional phenotypes of two primary HIV-1 strains resulting from homologous point mutations in the LLP domains of the envelope gp41 intracytoplasmic domain.
P2860
Q27485043-F5D2D096-7A78-4C8E-8B17-1143DAB44CB7Q33584712-DC308B4D-9022-450B-841B-CD1DA2DB0BB1Q33647178-7A3B9A3A-4940-4B7C-B94B-59ABC67233AFQ33938255-67A8EB2F-B3C5-46E0-A42A-EA20B54A852FQ34509684-893FF2D8-C019-4ED2-9283-990FFA53F834Q34713859-A5D5769D-5008-4C5C-9120-238D48E8D6C6Q36646981-5A4994F9-CC4B-4013-9023-58462608EBA1Q36670375-AF85554F-0881-4311-B988-FCABCD7A23EDQ37026697-9A41A0B4-1745-4047-940D-6E6BA8761D1BQ39627844-C376007B-5E94-4F74-A3BB-5DDEF4B7CA9BQ39652098-CA4A3F97-DB28-4828-BF22-C98D481DCFACQ40732333-3165EB5E-F01B-47DC-87AC-D6B4CF90CA8FQ41226592-BC4A34F9-6B96-4924-A45C-E94EAE3077EEQ41877292-3B1CDAC3-8820-4D3D-85AB-F45D75FAB00DQ41892359-A9FBF98D-DA98-484B-9F17-68DCA0A3ADAAQ42732524-693BB9CD-212C-4DEA-8A63-7413E807FD40Q55508034-7F339630-E8C3-44BB-A3FF-92B9C0B6FD51
P2860
Novel antimicrobial peptides derived from human immunodeficiency virus type 1 and other lentivirus transmembrane proteins.
description
1997 nî lūn-bûn
@nan
1997 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Novel antimicrobial peptides d ...... ivirus transmembrane proteins.
@ast
Novel antimicrobial peptides d ...... ivirus transmembrane proteins.
@en
type
label
Novel antimicrobial peptides d ...... ivirus transmembrane proteins.
@ast
Novel antimicrobial peptides d ...... ivirus transmembrane proteins.
@en
prefLabel
Novel antimicrobial peptides d ...... ivirus transmembrane proteins.
@ast
Novel antimicrobial peptides d ...... ivirus transmembrane proteins.
@en
P2093
P2860
P1476
Novel antimicrobial peptides d ...... ivirus transmembrane proteins.
@en
P2093
D J Creighton
J P Douglass
R C Montelaro
S B Tencza
T A Mietzner
P2860
P304
P407
P577
1997-11-01T00:00:00Z